Final Program

154 MONDAY • MAY 16
718 Health Resource Utilization of Asthma Hospitalizations with
Comorbid Sleep Apnea and Obesity: Results from the
Nationwide Inpatient Sample/M.B. Becerra, B.J. Becerra, M.
Teodorescu, San Bernardino, CA, p.A3111
719 Does Sleep Quantity and Quality Differ in ICU Patient with and
Without Delirium?/K.J. Bosma, D. Ovakim, M. Sen, G.K. Dresser,
P. Jones, London, Canada, p.A3112
B30
POSTER DISCUSSION SESSION
MOLECULAR AND IMMUNOLOGICAL ASPECTS OF
LUNG CANCER
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 309 (South Building, Esplanade Level)
Author Summaries 9:00-9:30
Poster Viewing/Discussion 9:30-11:00
Chairing: C.A. Powell, MD, New York, NY
301 Low Density Deutrophils (LDN) - a Newly Described Subset of
Tumor-Permissive Circulating Neutrophils in Advanced Lung
Cancer/Z.G. Fridlender, O. Eyal, J. Michaeli, P. Damti, J.Y. Sagiv,
I. Mishalian, M. Shaul, Z. Granot, Jerusalem, Israel, p.A3113
302 Suppression of B Lymphopoiesis by Myeloid-Derived
Suppressor Cells in Tumor-Bearing Mice/J.S. Deshane, Y.
Wang, C.C. Schafer, J.F. Kearney, H.-C. Hsu, Birmingham, AL,
p.A3114
303 Highly Exhausted T Cell Subsets in Human NSCLC Are
Co-Defined by the Predominant Expression of Distinct
Inhibitory Receptors/W.A. Moersig, D.S. Thommen, F.
Uhlenbrock, P. Herzig, S. Savic Prince, A. Zippelius, D. Lardinois,
Basel, Switzerland, p.A3115
304 Potential of Autoimmune Response Against Tumor-Associated
Antigens to Predict Risk of Developing Lung Cancer/J.J. Tsay,
L. Dai, T.-A. Yie, J. Munger, H. Pass, E. Tan, J. Zhang, W.N. Rom,
New York, NY, p.A3116
305 Characterizing the Role of Immune Cells in the FGF9-Induced
Lung Adenocarcinoma Mouse Model/A.E.M. Hegab, T.
Kinoshita, T. Yaguchi, Y. Kawakami, D. Ornitz, T. Betsuyaku,
Tokyo, Japan, p.A3117
306 Cytotoxic T Lymphocyte Antigen 4 (CTLA4) in Non-Small Cell
Lung Cancer/J. Li, H. Zhang, P. Dutta, N. Sabri, W.X. Li, La Jolla,
CA, p.A3118
307 Impact Of Interleukin-22 On K-ras Mutant Lung Cancer
Promotion And Stemness Properties/N. Khosravi, A.M.
Cumpian, S. Daliri, M.S. Caetano, S.J. Moghaddam, Houston, TX,
p.A3119
308 IL-17-Mediated Inflammation Promotes Cigarette
Smoke-Induced Genomic Instability/C. Cao, H. Zhou, B. Tian, Z.
Chen, W. Li, S. Ying, H. Shen, Hangzhou, China, p.A3120
309 Tumor-Suppressive microRNAs Modulate Oncogenic Signaling
Pathways in Lung Squamous Cell Carcinoma/H. Mataki, A.
Uchida, T. Kumamoto, K. Kamikawaji, K. Mizuno, H. Inoue,
Kagoshima, Japan, p.A3121
310 Deep Sequencing Reveals Unique MicroRNA Profile Alterations in
Serum of Lung Cancer Patients that Depends on Cigarette
Smoking/B. Ortiz-Quintero, L.V. Gayosso-Gomez, R. Falfan-Valencia,
P. Castillo-Gonzalez, R. Sansores, A. Ramirez-Venegas, M.E.
Vazquez-Manriquez, Mexico City, Mexico, p.A3122
311 Expression of MiR-200c Associates with Overall Survival and
Progression Free Survival Under Epidermal Growth Factor
Receptor- Tyrosine Kinase Inhibitor (EGFR-TKI) of Non Small
Cell Lung Cancer (NSCLC) Patient Harboring EGFR Common
Mutation/H.-Y. Wang, J.-Y. Shih, Yunlin County, Taiwan, p.A3123
312 Intracellular Redox Active Metal Ions Mediate the Differential
Susceptibility of NSCLC Cells to Pharmacological Ascorbate/J.D.
Schoenfeld, Z.A. Sibenaller, K. Cramer-Morales, C.M. Doskey, K.A.
Mapuskar, K.R. Parekh, J.C. Keech, J.J. Cullen, G.R. Buettner, F.R.
Domann, D.R. Spitz, B.G. Allen, Iowa City, IA, p.A3124
313 Lung Cancer Associations Are Enriched for Regulatory
Variants in Non-Tumor Lung Tissue/M. Obeidat, Y. Nie, Y.
Bosse, M. Laviolette, K. Hao, D.C. Nickle, D.S. Postma, W. Timens,
R.J. Hung, W.L. Lam, E.A. Vucic, P.D. Pare, D.D. Sin, Vancouver,
Canada, p.A3125
314 Novel Regulators of Metastases in Lung Squamous
Carcinoma/A. Belanger, A. Porrello, S. Azam, S. Ghosh, T.
Waugh, M. Smith, C. Pecot, Chapel Hill, NC, p.A3126
315 Overexpression of Slug Drives Malignant Phenotypes in Models
of Lung Premalignancy and Cancer/B.S. Grimes, T.C. Walser, R.
Li, Z. Jing, L. Tran, S.M. Dubinett, Los Angeles, CA, p.A3127
316 LincRNA-p21 Impacts Prognosis in Non-Small Cell Lung
Cancer Adenocarcinoma Patients/J. Moises, J. Castellano, J.
Ramirez, A. Cordeiro, N. Vinolas, A. Saco, M. Ruiz, S.
Santasusagna, F. Aya, L. Molins, A. Navarro, M. Monzo, R.M.
Marrades, Barcelona, Spain, p.A3128
317 Ciz1b Variant as a Surrogate Marker in Surveillance of Lung
Cancer Recurrence/V. Ifeacho, M. Risco, A. Ryazantsev, O. James,
G. Rubiaco, K. Almodovar, D. Upadhyay, Fresno, CA, p.A3129
318 Long Non-Coding RNA FAM83H-AS1 Promotes Tumor
Progression and Related to Disease Free Survival in Lung
Adenocarcinomas/J. Zhang, Xi’an, China, p.A3130
319 MARCKS-Inhibitory Peptides Synergize with Cisplatin to
Inhibit Metastasis and Primary Tumor Growth in Mouse
Orthotopic Lung Cancer Models/Q. Yin, S. Fang, J. Park, A.
Crews, I. Parikh, B. Dickson, K. Adler, Raleigh, NC, p.A3131
320 Cancer Associated Fibroblast Promotes Non-Small Cell Lung
Cancer Invasiveness by Activating GRP78 Expression on an
Integreated Bionic Microfluidic Device/Q. Wang, T. Yu, Z. Guo,
Dalian, China, p.A3132
ATS 2016 • San Francisco